Profile
International Journal of Pediatrics & Neonatal Care Volume 1 (2015), Article ID 1:IJPNC-109, 3 pages
http://dx.doi.org/10.15344/2455-2364/2015/109
Expert Opinion
Diagnosis and Treatment in Pediatric Acute Lymphoblastic Leukemia for General Pediatricians

Der-Cherng Liang

Department of Pediatrics, Mackay Children’s Hospital and School of Medicine Mackay Medical College, Taipei, Taiwan
Dr. Der-Cherng Liang, Department of Pediatrics, Mackay Children’s Hospital and School of Medicine Mackay Medical College, Taipei, Taiwan; E-mail: dcliang@mmh.org.tw
21 March 2015; 19 September 2015; 21 September 2015
Liang DC (2015) Diagnosis and Treatment in Pediatric Acute Lymphoblastic Leukemia for General Pediatricians. Int J Pediatr Neonat Care 1: 109. doi: http://dx.doi.org/10.15344/2455-2364/2015/109
This work is supported by a Grant No MMH-E-103-09 from Mackay Children’s Hospital, Taipei, Taiwan.

References

  1. Pui CH, Carroll WL, Meshinchi S, Arceci RJ (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 29: 551- 565 [CrossRef] [Google Scholar] [PubMed]
  2. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, et al. (2012) Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol 30: 1663-1669 [CrossRef] [Google Scholar] [PubMed]
  3. Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, et al. (2010) Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24: 265-284 [CrossRef] [Google Scholar] [PubMed]
  4. Vora A, Goulden N, Mitchell C, et al (2014) Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukemia (UKALL 2003): a randomised controlled trial. Lancet Oncol 15:809-818 [CrossRef] [Google Scholar] [PubMed]
  5. Pui C-H (2012) Acute lymphoblastic leukemia. In: Pui C-H (Ed). Childhood Leukemia, 3rd Edn. Cambrige University Press, New York, pp.332-366 [Google Scholar]
  6. Raimondi SC (2012) Cytogenetics of acute lymphoblastic leukemia. In: Pui C-H (Ed). Childhood Leukemia, 3rd Edn. Cambrige University Press, New York, pp.135-167
  7. Mullighan CG (2012) Molecular genetics of acute lymphoblastic leukemia. In: Pui C-H (Ed). Childhood Leukemia, 3rd Edn. Cambrige University Press, New York, pp.168-203
  8. Liang DC, Shih LY, Yang CP, Hung IJ, Liu HC, et al. (2010) Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west. Pediatr Blood Cancer 55: 430- 433 [CrossRef] [Google Scholar] [PubMed]
  9. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, et al. (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. See comment in PubMed Commons below N Engl J Med 360: 2730-2741 [CrossRef] [Google Scholar] [PubMed]
  10. Manabe A, Tsuchida M, Hanada R, Ikuta K, Toyoda Y, et al. (2001) Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12. J Clin Oncol 19: 3182-3187 [CrossRef] [Google Scholar] [PubMed]
  11. Liu HC, Yeh TC, Hou JY, Chen KH, Huang TH, et al. (2014) Triple intrathecal therapy alone with omission of cranial radiation in children with acute lymphoblastic leukemia. J Clin Oncol 32:1825-1829 [CrossRef] [Google Scholar] [PubMed]
  12. Yeh TC, Liu HC, Hou JY, Chen KH, Huang TH, et al. (2014) Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis. Cancer 120: 1255-1262 [CrossRef] [Google Scholar] [PubMed]
  13. Pui CH (2015) Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Front Med 9: 1-9 [CrossRef] [Google Scholar] [PubMed]
  14. Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, et al. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10: 147-156 [CrossRef] [Google Scholar] [PubMed]
  15. Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, et al. (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360: 470-480 [CrossRef] [Google Scholar] [PubMed]
  16. Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs- Gladdines JG, et al (2009) A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genomewide classification study. Lancet Oncol 10: 125-134 [CrossRef] [Google Scholar] [PubMed]
  17. Roberts KG, Pei D, Campana D, Payne-Turner D, Li Y, et al. (2014) Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. J Clin Oncol 32: 3012-3020 [CrossRef] [Google Scholar] [PubMed]
  18. Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, et al. (2014) Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371: 1005-1015 [CrossRef] [Google Scholar] [PubMed]